SAVA
Price:
$1.32
Market Cap:
$60.38M
Cassava Sciences, Inc. is a biopharmaceutical enterprise in the clinical development phase, specializing in the creation of treatments for neurodegenerative disorders. The company's primary experimental drug, simufilam, a small-molecule compound, has successfully concluded its Phase 2b clinical trials. In parallel, they are advancing SavaDx, an investigational blood-based biomarker test designed to aid in the detection of Alzheimer's disease. Established in 1998 and headquartered in Austin, Texas, the company underwent a name change in March 2019, previously operating as Pain Therapeutics, Inc.
Industry
Biotechnology
IPO Date
2000-07-14
Stock Exchange
NASDAQ
Ticker
SAVA
According to Cassava Sciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.19. This represents a change of -3.77% compared to the average of 2.28 of the last 4 quarters.
The mean historical Current Ratio of Cassava Sciences, Inc. over the last ten years is 0.45. The current 2.19 Current Ratio has changed 49.09% with respect to the historical average. Over the past ten years (40 quarters), SAVA's Current Ratio was at its highest in in the December 2024 quarter at 11.62. The Current Ratio was at its lowest in in the March 2026 quarter at 2.19.
Average
0.45
Median
0
Minimum
0
Maximum
2.23
Discovering the peaks and valleys of Cassava Sciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Current Ratio = 2.23
Minimum Annual Increase = 0%
Minimum Annual Current Ratio = 0
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 2.23 | Infinity% |
| 2024 | 0 | 0% |
| 2023 | 0 | 0% |
| 2022 | 0 | 0% |
The current Current Ratio of Cassava Sciences, Inc. (SAVA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
0.74
5-year avg
0.45
10-year avg
0.45
Cassava Sciences, Inc.’s Current Ratio is less than Alector, Inc. (5.25), less than PepGen Inc. (14.98), less than Cybin Inc. (13.78), less than Molecular Partners AG (9.42), less than Nkarta, Inc. (12.96), less than Cardiff Oncology, Inc. (3.27), less than Fate Therapeutics, Inc. (5.85), less than Milestone Pharmaceuticals Inc. (9.18), less than Rani Therapeutics Holdings, Inc. (3.40), less than Elicio Therapeutics, Inc. (2.24),
| Company | Current Ratio | Market cap |
|---|---|---|
| 5.25 | $169.87M | |
| 14.98 | $101.68M | |
| 13.78 | $413.02M | |
| 9.42 | $154.17M | |
| 12.96 | $204.62M | |
| 3.27 | $105.29M | |
| 5.85 | $240.11M | |
| 9.18 | $109.08M | |
| 3.40 | $49.65M | |
| 2.24 | $283.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cassava Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cassava Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Cassava Sciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for Cassava Sciences, Inc. (SAVA)?
What is the highest Current Ratio for Cassava Sciences, Inc. (SAVA)?
What is the 3-year average Current Ratio for Cassava Sciences, Inc. (SAVA)?
What is the 5-year average Current Ratio for Cassava Sciences, Inc. (SAVA)?
How does the current Current Ratio for Cassava Sciences, Inc. (SAVA) compare to its historical average?